Sun Pharma Advanced Research Company (Sparc) Said That Us Food And Drug Administration (Fda) Has Granted Orphan Drug Designation To Phenobarbital For The Treatment Of Patients With Neonatal Seizures.The Orphan Drug Act Provides Economic Incentives To Encourage The Development Of Drugs For Diseases Affecting Fewer Than 200,000 People In The United States, Sparc Said.Orphan Drug Designation Will Grant Seven Years Of Us Market Exclusivity Upon Approval Of Phenobarbital For The Treatment Of Patients With Neonatal Seizures, The Company Said.Incentives Include Waiver Of User Fee By Us Fda And Assistance In Clinical Trial Design By Us Fda.
Sick and tired of always wondering if you are being asked to pay the right price for your APIs? This empowers you with the answers you need to make the right decisions in the Global API market.
Chemxpert Database is one of the biggest and most comprehensive directories of pharma and chemicals, manufacturers, suppliers and information. Provided with current information on prices, demand and transactions, it gives you instant feedback on whether you are buying what is right and at the right time.
Start using market intelligence today and allow yourself to be in control in the API market.
Check it out today and make more informed sourcing decisions! Learn More!